PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
Blue Cap AG publishes preliminary financial figures for 2025: successful financial year 2025
Blue Cap AG reports successful financial year 2025 with EUR 129.1 million revenue and 5.5% adjusted EBITDA margin. Focus on Industrials and Business Services segments. Forecast for 2026 remains stable -
-
-
PRESS RELEASE
2025 annual results: strong improvement in financial earnings and cash-flows
Exail Technologies achieved significant financial growth in 2025 with record order intake of €844 million (+87%), revenue growth of +28%, and strengthened balance sheet post fundraising of €300 million. Operational milestones include delivering mine countermeasures to navies and increasing production capacity for navigation systems -
PRESS RELEASE
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms -
PRESS RELEASE
Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy -
PRESS RELEASE
SMG reports strong 2025 results with significant margin uplift
SMG Swiss Marketplace Group reports strong 2025 financial results with revenue of CHF 332.0 million and Adjusted EBITDA up to CHF 180.2 million, lifting margin to 54.3%. Continues innovating with AI for user experience and efficiency
